NYSE · CVS
Healthcare · Medical - Healthcare Plans
$88.84
Down-$1.43 (-1.58%)
Updated Sep 20, 2026, 8:46 AM
SID Score
5.8/10
Composite research score
Smart Money
62/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
CVS closed at $88.84 after 19 trading sessions, down 5.60% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $90.09 | $90.48 | $88.15 | $88.84 | 21.88M |
| Sep 17, 2026 | $92.00 | $92.1367 | $90.165 | $90.27 | 7.43M |
| Sep 16, 2026 | $94.46 | $94.95 | $91.44 | $91.72 | 7.24M |
| Sep 15, 2026 | $95.74 | $95.75 | $93.84 | $94.49 | 5M |
| Sep 14, 2026 | $95.44 | $96.01 | $95.28 | $95.55 | 4.45M |
| Sep 11, 2026 | $95.78 | $96.41 | $93.91 | $94.66 | 4.38M |
| Sep 10, 2026 | $96.01 | $97.32 | $94.88 | $95.29 | 3.88M |
| Sep 9, 2026 | $97.39 | $97.98 | $92.7897 | $95.38 | 6.11M |
| Sep 8, 2026 | $95.83 | $96.73 | $95.24 | $96.07 | 4.2M |
| Sep 4, 2026 | $96.59 | $97.69 | $96.285 | $96.74 | 4.5M |
| Sep 3, 2026 | $97.10 | $98.07 | $95.67 | $97.20 | 4.78M |
| Sep 2, 2026 | $97.82 | $98.4999 | $96.90 | $97.23 | 5.4M |
| Sep 1, 2026 | $94.99 | $97.61 | $94.68 | $97.60 | 8.61M |
| Aug 31, 2026 | $93.22 | $94.37 | $92.85 | $93.91 | 10.68M |
| Aug 28, 2026 | $93.40 | $93.93 | $93.01 | $93.06 | 3.99M |
| Aug 27, 2026 | $93.60 | $94.15 | $92.85 | $92.92 | 4.33M |
| Aug 26, 2026 | $93.15 | $94.855 | $92.91 | $94.32 | 6.16M |
| Aug 25, 2026 | $94.11 | $94.11 | $92.71 | $92.90 | 4.1M |
| Aug 24, 2026 | $93.15 | $94.19 | $92.54 | $94.11 | 9.23M |
The latest Smart Investors Daily articles mentioning CVS.
CVS research
Company profile and research snapshot.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | UBS | Buy | — |
| Aug 19, 2026 | Argus Research | Buy | — |
| Aug 12, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
Generated Sep 19, 2026, 9:17 PM
CVS Health shares declined 1.58% today despite a mix of operational developments and strategic healthcare initiatives. While the company reported strong Q2 earnings performance and announced meaningful expansions in its insurance operations, broader market headwinds and a completed bankruptcy liquidation in one division appear to be weighing on investor sentiment.
Bottom line: CVS is trading lower today despite encouraging operational news, suggesting investors may be focused on sector-wide retail and healthcare pressures rather than the company's specific accomplishments. The expansion of Aetna's prior authorization initiatives and strong Q2 earnings provide positive catalysts, but monitoring the company's ability to maintain margins amid competitive intensity and broader economic softness remains critical for investors.
Yahoo · Sep 18, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).
Yahoo · Sep 18, 2026
The sale lets Ascension shed insurance risk while Aetna gains a stake in a profitable plan serving high-margin dual-eligible members.
Yahoo · Sep 18, 2026
A piece of the company is winding down its operations under CVS Health.
Yahoo · Sep 18, 2026
Originally published on Company NewsroomThe new mini-pitch brings safe access to play to Orchards Elementary School in Vancouver, WA, as part of 's multi-year field revitalization commitmentNORTHAMPTON, MA AND WOONSOCKET, RI / ACCESS Newswire / September 18, 2026 / ® (NYSE:CVS) announced it has redeveloped a mini soccer pitch in collaboration with Seattle Reign FC and the club's charitable arm, the RAVE Foundation. The mini-pitch, which is located at Orchards Elementary in Vancouver, WA, is now
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CVS.
